Projects per year
Personal profile
Research Statement
The Stratified Medicine Group focuses on the following areas:
1) Characterisation of a molecular group in solid cancers that represents an innate immune response to DNA damage through the STING pathway.
2) Development of a biomarker for anti-angiogenic agents
3) Development of a biomarker for MEKK pathway activation
4) Identification of a prognostic biomarker for early prostate cancer
5) Development of new cell lines for pre-clinical modelling of ovarian and prostate cancer.
Other
Linked in Profile:
https://www.linkedin.com/in/profkennedy/
Fingerprint Dive into the research topics where Richard Kennedy is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 93 Similar Profiles
Breast Neoplasms
Medicine & Life Sciences
Neoplasms
Medicine & Life Sciences
DNA Damage
Medicine & Life Sciences
Biomarkers
Medicine & Life Sciences
Ovarian Neoplasms
Medicine & Life Sciences
Paraffin
Medicine & Life Sciences
Formaldehyde
Medicine & Life Sciences
Triple Negative Breast Neoplasms
Medicine & Life Sciences
Network
Recent external collaboration on country level. Dive into details by clicking on the dots.
Projects 2012 2019
R1005PMY: Artificial Intelligence Enables Clinical Decision Making in the Digital Healthcare Era
McArt, D., Kennedy, R. & Salto-Tellez, M.
12/02/2019 → …
Project: Research
R1523CNR: “S-CORT: Stratification in COloRectal cancer: from biology to Treatment prediction”.
Lawler, M., Johnston, P., Kennedy, R., Salto-Tellez, M. & Wilson, R.
29/04/2015 → …
Project: Research
R2116CNR: MOVEMBER CENTRE OF EXCELLENCE
O'Sullivan, J., Jain, S., Kennedy, R., McDade, S., Prise, K., Salto-Tellez, M. & Waugh, D.
21/05/2014 → …
Project: Research
R6416CNR: Phase 1B/II study of MEK1/2 inhibitor PD-0325901 with cMET inhibitor PF-02341066 in KRASMT and KRASWT (with aberrant c-MET) Colorectal Cancer Patients
Van Schaeybroeck, S., Johnston, P., Kennedy, R., Lawler, M., Longley, D., Salto-Tellez, M. & Wilson, R.
01/08/2013 → …
Project: Research
Research Output 1994 2019
A Novel Role for Cathepsin S as a Potential Biomarker in Triple Negative Breast Cancer
Wilkinson, R., Burden, R., McDowell, S., McArt, D., McQuaid, S., Bingham, V., Williams, R., Cox, O., O'Connor, R., McCabe, N., Kennedy, R., Buckley, N. E. & Scott, C., 28 Jun 2019, In : Journal of Oncology.Research output: Contribution to journal › Article
Open Access
File
cathepsin S
Triple Negative Breast Neoplasms
Biomarkers
Neoplasms
DNA Repair
Defining an IBD-like subgroup in consensus molecular subgroups of colorectal cancer and transcriptomic biomarker development for at-risk patients.
Scanlon, E., Murphy, S. J., Kennedy, R. D. & Blayney, J. K., 26 May 2019, In : Journal of Clinical Oncology : official journal of the American Society of Clinical Oncology. 37, 15_supplResearch output: Contribution to journal › Meeting abstract
Tumor Biomarkers
Ulcerative Colitis
Colorectal Neoplasms
Cluster Analysis
Mutation
Defining the molecular evolution of extrauterine high grade serous carcinoma
Beirne, J. P., McArt, D. G., Roddy, A., McDermott, C., Ferris, J., Buckley, N. E., Coulter, P., McCabe, N., Eddie, S. L., Dunne, P. D., O'Reilly, P., Gilmore, A., Feeney, L., Ewing, D. L., Drapkin, R. I., Salto-Tellez, M., Kennedy, R. D., Harley, I. J. G., McCluggage, W. G. & Mullan, P. B., 04 Sep 2019, In : Gynecologic Oncology. 155, 2, p. 305-317 13 p.Research output: Contribution to journal › Article
Molecular Evolution
Carcinoma
Fallopian Tubes
Carcinoma in Situ
Epithelium
DNA Repair Deficiency in Breast Cancer: Opportunities for Immunotherapy
Gilmore, E., McCabe, N., Kennedy, R. & Parkes, E., 19 Jun 2019, In : Journal of Oncology.Research output: Contribution to journal › Article
Open Access
File
DNA Repair-Deficiency Disorders
Immunotherapy
Breast Neoplasms
Therapeutics
Tumor Microenvironment
High EMSY expression defines a BRCA-like subgroup of high-grade serous ovarian carcinoma with prolonged survival and hypersensitivity to platinum
Hollis, R. L., Churchman, M., Michie, C. O., Rye, T., Knight, L., McCavigan, A., Perren, T., Williams, A. R. W., McCluggage, W. G., Kaplan, R. S., Jayson, G. C., Oza, A., Harkin, D. P., Herrington, C. S., Kennedy, R. & Gourley, C., 15 Aug 2019, In : Cancer. 125, 16, p. 2772-2781 10 p.Research output: Contribution to journal › Article
Open Access
File
Platinum
Hypersensitivity
Carcinoma
Recombinational DNA Repair
Survival
Prizes
Queen’s University of Belfast Vice Chancellor Award for Innovation
Richard Kennedy (Recipient), 2013
Prize: Prize (including medals and awards)
St Luke’s Medal for Cancer Research. Royal College of Medicine, Ireland
Richard Kennedy (Recipient), 2015
Prize: Prize (including medals and awards)
Press / Media
Behind the Science. 30 minute TV programme on Cancer Research at QUB/Almac
13/12/2017
1 media contribution
Press/Media: Public Engagement Activities
A visit to the Doctor in 2013. Public lecture.
10/10/2017
1 item of media coverage
Press/Media: Public Engagement Activities
Impact
Development and Commercialization of a Technology Platform to Enable Biomarker Discovery and Validation
Richard Kennedy (Participant), Paul Harkin (Participant), Patrick Johnston (Participant), Alison Hosey (Participant), Julia Miskelly (Participant), Margaret Murray (Participant), Jennifer Quinn (Participant), Colin James (Participant), Jude Mulligan (Participant), Peter Daly (Participant), Paul Mullan (Participant), Julie Mussen (Participant), Ultan McDermott (Participant), Richard Wilson (Participant), Daniel Longley (Participant)
Impact: Health Impact, Quality of Life Impact